Heartflow, INC Schedule 13G passive stakes

BCLS Fund III Investments, LP has reported a beneficial ownership of 8,448,158 shares, representing 9.8% of Heartflow, Inc.'s common stock as of June 30, 2026.

Wellington Management Group LLP and its affiliates have reported a beneficial ownership of 10.7% in Heartflow, Inc. common stock as of July 31, 2026.

Several Hayfin entities have reported a reduction in their beneficial ownership of HeartFlow, Inc. Class A Common Stock, with aggregate holdings now below 5% for some.

HealthCor Partners Management LP and its affiliated funds reported a significant reduction in their beneficial ownership of Heartflow, Inc. common stock following a distribution to fund investors.

Wellington Management Group and its affiliates reported a 14.0% beneficial ownership in Heartflow, Inc.'s common stock.

Wellington Management Group LLP and its affiliates have reported a 6.9% beneficial ownership stake in Heartflow, Inc. common stock.

HealthCor Partners Management LP and affiliated funds have reported a 7.9% beneficial ownership stake in Heartflow, Inc., totaling 6,697,556 common shares.

BCLS Fund III Investments, LP, a Bain Capital Life Sciences entity, has reported a 14.9% beneficial ownership stake in Heartflow, Inc., holding 12,448,158 shares of common stock.

Hayfin Management Holdings Limited and its affiliates have reported a 6.2% beneficial ownership stake in Heartflow, Inc.'s Class A Common Stock.

Wellington Management Group LLP and its affiliates have reported a 5.85% beneficial ownership stake in Heartflow, Inc. common stock.

FMR LLC and Abigail P. Johnson have reported a 5.7% beneficial ownership stake in HeartFlow Inc's common stock as of September 30, 2025.